JESSICA TISCI: Open Payments
NPI 1225098635 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,815 in 161 payments from 14 companies in 2025. Trend: 2023 $3,657 · 2024 $3,533 · 2025 $2,815
Food & beverage: $2,725Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $432 |
| UCB, Inc. | 19 | $366 |
| Novartis Pharmaceuticals Corporation | 32 | $340 |
| ABBVIE INC. | 21 | $328 |
| Galderma Laboratories, L.P. | 12 | $242 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $232 |
| PFIZER INC. | 15 | $225 |
| Incyte Corporation | 9 | $210 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Lilly USA, LLC | 4 | $107 |
Products named: TREMFYA, Bimzelx, COSENTYX, SKYRIZI, NEMLUVIO, CIBINQO, OPZELURA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
